Chief Executive Officer of French artificial heart manufacturer Carmat, Stephane Piat, poses holding an artificial heart during an interview with Reuters in Velizy, near Paris
French artificial heartmaker Carmat (ALCAR.PA) announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman.
The company said the procedure had been performed at the UofL Health - Jewish Hospital by University of Louisville physicians in the United States.
"This third implant in the U.S. was a landmark event not only because it allowed us to finalize the enrollment of the first cohort of patients of the EFS (early feasibility study), but very importantly because it is the first time ever that our device has helped a woman suffering from heart failure," Carmat CEO Stephane Piat said in a statement.
Reporting by Matthieu Protard; Editing by Sudip Kar-Gupta
Qatar Airways brings its Airbus A380 aircraft back into operation for winter peak season
Pfizer says its antiviral pill slashes risk of severe COVID-19 by 89%
What are the Best-paying Jobs in Qatar?
Umrah and prayer at Grand Mosque permits restricted for fully vaccinated pilgrims from Oct. 10